29th Apr 2016 17:14
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) and (c) I give details of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1496.49 pence per Share, following the re-investment of the dividend paid to shareholders on 14 April 2016.
Director/PDMR
|
Shares |
Sir Andrew Witty
| 2,257.407 |
Mr R Connor | 552.391 |
Mr S A Hussain | 1,460.067 |
Mr D S Redfern | 2,129.312 |
Dr M M Slaoui | 4.719 |
Ms C Thomas | 2,692.384 |
Mr P C Thomson | 1,002.153 |
Dr P J T Vallance
| 3,827.535 |
Ms E Walmsley
| 2,705.444 |
Connected Person |
Shares |
Mrs K Thomson (Connected Person to Mr P C Thomson)
| 251.103 |
GSK was informed of these allocations on 28 April 2016.
V A Whyte
Company Secretary
29 April 2016
Related Shares:
Glaxosmithkline